CURLF
Price
$3.20
Change
+$0.04 (+1.27%)
Updated
Aug 27 closing price
Capitalization
2.44B
74 days until earnings call
TSNDF
Price
$1.11
Change
-$0.04 (-3.48%)
Updated
Aug 27 closing price
Capitalization
338.04M
82 days until earnings call
Interact to see
Advertisement

CURLF vs TSNDF

Header iconCURLF vs TSNDF Comparison
Open Charts CURLF vs TSNDFBanner chart's image
Curaleaf
Price$3.20
Change+$0.04 (+1.27%)
Volume$1.81M
Capitalization2.44B
TerrAscend
Price$1.11
Change-$0.04 (-3.48%)
Volume$748.74K
Capitalization338.04M
CURLF vs TSNDF Comparison Chart in %
Loading...
CURLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CURLF vs. TSNDF commentary
Aug 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CURLF is a Buy and TSNDF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 28, 2025
Stock price -- (CURLF: $3.20 vs. TSNDF: $1.11)
Brand notoriety: CURLF and TSNDF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CURLF: 161% vs. TSNDF: 109%
Market capitalization -- CURLF: $2.44B vs. TSNDF: $338.04M
CURLF [@Pharmaceuticals: Generic] is valued at $2.44B. TSNDF’s [@Pharmaceuticals: Generic] market capitalization is $338.04M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.86B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CURLF’s FA Score shows that 0 FA rating(s) are green whileTSNDF’s FA Score has 1 green FA rating(s).

  • CURLF’s FA Score: 0 green, 5 red.
  • TSNDF’s FA Score: 1 green, 4 red.
According to our system of comparison, TSNDF is a better buy in the long-term than CURLF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CURLF’s TA Score shows that 3 TA indicator(s) are bullish while TSNDF’s TA Score has 2 bullish TA indicator(s).

  • CURLF’s TA Score: 3 bullish, 4 bearish.
  • TSNDF’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, CURLF is a better buy in the short-term than TSNDF.

Price Growth

CURLF (@Pharmaceuticals: Generic) experienced а +22.74% price change this week, while TSNDF (@Pharmaceuticals: Generic) price change was +12.23% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.19%. For the same industry, the average monthly price growth was +10.32%, and the average quarterly price growth was +79.93%.

Reported Earning Dates

CURLF is expected to report earnings on Nov 10, 2025.

TSNDF is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.19% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CURLF($2.44B) has a higher market cap than TSNDF($338M). CURLF YTD gains are higher at: 105.353 vs. TSNDF (70.785). CURLF has higher annual earnings (EBITDA): 220M vs. TSNDF (11.3M). CURLF has more cash in the bank: 102M vs. TSNDF (27.7M). TSNDF has less debt than CURLF: TSNDF (242M) vs CURLF (843M). CURLF has higher revenues than TSNDF: CURLF (1.29B) vs TSNDF (300M).
CURLFTSNDFCURLF / TSNDF
Capitalization2.44B338M721%
EBITDA220M11.3M1,947%
Gain YTD105.35370.785149%
P/E RatioN/A111.01-
Revenue1.29B300M429%
Total Cash102M27.7M368%
Total Debt843M242M348%
FUNDAMENTALS RATINGS
CURLF vs TSNDF: Fundamental Ratings
CURLF
TSNDF
OUTLOOK RATING
1..100
2327
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
82
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9698
PRICE GROWTH RATING
1..100
3434
P/E GROWTH RATING
1..100
1006
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CURLF's Valuation (51) in the null industry is in the same range as TSNDF (82). This means that CURLF’s stock grew similarly to TSNDF’s over the last 12 months.

CURLF's Profit vs Risk Rating (100) in the null industry is in the same range as TSNDF (100). This means that CURLF’s stock grew similarly to TSNDF’s over the last 12 months.

CURLF's SMR Rating (96) in the null industry is in the same range as TSNDF (98). This means that CURLF’s stock grew similarly to TSNDF’s over the last 12 months.

CURLF's Price Growth Rating (34) in the null industry is in the same range as TSNDF (34). This means that CURLF’s stock grew similarly to TSNDF’s over the last 12 months.

TSNDF's P/E Growth Rating (6) in the null industry is significantly better than the same rating for CURLF (100). This means that TSNDF’s stock grew significantly faster than CURLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CURLFTSNDF
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 13 days ago
89%
Bearish Trend 28 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
CURLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCSCX11.180.09
+0.81%
M3Sixty Small Cap Growth
TAGRX70.03N/A
N/A
JHancock Fundamental Large Cap Core A
TCGLX58.15N/A
N/A
Touchstone Large Company Growth C
OBSIX27.96N/A
N/A
Oberweis Small-Cap Opportunities Instl
ARAQX11.26N/A
N/A
Aristotle Value Eq A

CURLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CURLF has been closely correlated with GTBIF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if CURLF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CURLF
1D Price
Change %
CURLF100%
+1.44%
GTBIF - CURLF
82%
Closely correlated
-0.65%
TCNNF - CURLF
80%
Closely correlated
+1.01%
VRNOF - CURLF
78%
Closely correlated
-0.59%
CRLBF - CURLF
76%
Closely correlated
+2.37%
TSNDF - CURLF
75%
Closely correlated
-3.47%
More

TSNDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSNDF has been closely correlated with GTBIF. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TSNDF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSNDF
1D Price
Change %
TSNDF100%
-3.47%
GTBIF - TSNDF
78%
Closely correlated
-0.65%
CRLBF - TSNDF
76%
Closely correlated
+2.37%
TCNNF - TSNDF
76%
Closely correlated
+1.01%
CURLF - TSNDF
74%
Closely correlated
+1.44%
VRNOF - TSNDF
74%
Closely correlated
-0.59%
More